Childhood-juvenile multiple sclerosis: clinical characteristics and treatment (Q36153393)

12 August 2017

1 reference

title

Childhood-juvenile multiple sclerosis: clinical characteristics and treatment (English)

1 reference

12 August 2017

0 references

Angelo Ghezzi

1

1 reference

12 August 2017

publication date

1 May 2005

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

12 August 2017

published in

1 reference

12 August 2017

volume

5

1 reference

12 August 2017

issue

3

1 reference

12 August 2017

page(s)

403-411

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.3.403

12 August 2017

1 reference

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.3.403

Axonal pathology in multiple sclerosis: relationship to neurologic disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.3.403

Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.3.403

Multiple sclerosis in childhood: clinical features of 149 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.3.403

Prospective study of multiple sclerosis with early onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.3.403

Course and prognosis in early-onset MS: comparison with adult-onset forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.3.403

Early onset multiple sclerosis: a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.3.403

The natural history of early onset multiple sclerosis: comparison of data from Moscow and Vancouver

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.3.403

First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.3.403

Multiple sclerosis in children under 10 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.3.403

Multiple sclerosis in childhood and adolescence: clinical features and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.3.403

Multiple sclerosis in children under 6 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.3.403

Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.3.403

Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.3.403

Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.3.403

The bioavailability of IV methylprednisolone and oral prednisone in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.3.403

The 5-year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.3.403

Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.3.403

Glatiramer acetate treatment in patients with childhood and juvenile onset multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.3.403

Italian studies on early-onset multiple sclerosis: the present and the future.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.3.403

Childhood multiple sclerosis treated with plasmapheresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.3.403

Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.3.403

A Preliminary Diffusion Tensor and Magnetization Transfer Magnetic Resonance Imaging Study of Early-Onset Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.3.403

21 January 2018

Identifiers

DOI

10.1586/14737175.5.3.403

1 reference

12 August 2017

1 reference